ISG to Evaluate Enterprise Service Management in the U.S. and Worldwide
STAMFORD, Conn., April 11, 2025--(BUSINESS WIRE)--Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, has launched a research study examining providers that support the extension of IT service management (ITSM) practices into all facets of the digital enterprise.
The study results will be published in a pair of comprehensive ISG Provider Lens™ reports geared to enterprise buyers: Enterprise Service Management – Services, covering the U.S. market, and Enterprise Service Management – Software, covering the global market. The reports, scheduled to be released in September, will evaluate service providers that offer functional knowledge, industry process experience, and diverse IT and software support competencies to enterprises, along with industry-aligned intelligent solutions catering to specific sector requirements.
Enterprise buyers will be able to use information from the reports to evaluate their current vendor relationships, potential new engagements and available offerings, while ISG advisors use the information to recommend providers to the firm's buy-side clients.
Having evolved from the field of ITSM, enterprise service management (ESM) now encompasses various business and corporate functions, including HR, finance, operations and customer service, to create unified service experiences across organizations. Providers are working to develop AI-driven decision engines that optimize workflows, enhance predictive analytics and streamline service orchestration between the broader business and IT.
"In a digital-first era, ESM serves as a command center for data-driven decision-making, bridging enterprise functions and ensuring enterprise resilience," said Heiko Henkes, managing director, ISG Provider Lens Research. "Service providers in this space are redefining user engagement through self-service portals and intuitive architectures, improving user satisfaction and efficiency."
ISG has distributed surveys to more than 140 providers serving the U.S. ESM services market. Working in collaboration with ISG's global advisors, the research team will produce three quadrants representing the ESM services the typical enterprise is buying based on ISG's experience working with its clients. The three quadrants are:
Consulting and Advisory Services, evaluating providers on their expertise in driving enterprise service strategies, service design and engineering-led innovation across business, corporate and technology portfolios. These providers play critical roles in aligning strategic objectives with modern service management frameworks, ensuring operational excellence.
Implementation and Integration Services, assessing providers specializing in seamless enterprise service implementation, system integration, engineering-led innovation and service transition strategies across business, corporate and technology portfolios. Providers must demonstrate excellence in workflow management platforms, ensuring automation-driven process efficiency and integrating internal business systems with external systems to enhance enterprise-wide interoperability.
Managed Services for Converged IT and Business Ops, studying providers based on their expertise in enterprise service operations, performance optimization and continual service improvement across IT and business functions. Providers must leverage service automation, implementing AI-driven ITSM and workflow orchestration for enhanced operational efficiency, reliability and proactive monitoring.
In addition, ISG has distributed surveys to more than 40 providers of ESM software globally. This report will include the following quadrant:
Enterprise Service and Workflow Management Platforms, evaluating software providers of end-to-end enterprise workflow automation, integrating IT and the business with customer-facing services. These platforms extend traditional ITSM into broader enterprise-wide automation, covering IT, HR, finance, procurement and customer service.
ISG analyst Ashwin Gaidhani will serve as lead author of both reports.
A list of identified providers and vendors and further details on the study are available in these digital brochures: Enterprise Service Management – Services and Enterprise Service Management - Software. Companies not listed as ESM software and service providers can contact ISG and ask to be included in the study.
All 2025 ISG Provider Lens™ evaluations feature expanded customer experience (CX) data that measures actual enterprise experience with specific provider services and solutions, based on ISG's continuous CX research. Enterprise customers wishing to share their experience about a specific provider or vendor are invited to complete this online survey. Participants will receive a copy of this report in return for their feedback.
About ISG Provider Lens™ Research
The ISG Provider Lens™ Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage.
About ISG
ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world's top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250411075911/en/
Contacts
Press Contacts:
Will Thoretz, ISG+1 203 517 3119will.thoretz@isg-one.com
Julianna Sheridan, Matter Communications for ISG+1 978-518-4520isg@matternow.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Evercore adds Affirm to its Tactical Underperform list
-- Evercore ISI added Affirm Holdings (NASDAQ:AFRM) to its Tactical Underperform (TAP) list, citing stretched valuations and the stock's sharp rally heading into next week's earnings. Affirm shares have surged 115% since April and 18% since the start of August, making it the best performer year-to-date under Evercore's coverage. Analysts said the run-up leaves 'the risk/reward less favorable heading into next week's print than it was a few weeks ago.' The broker highlighted that Affirm is trading near its recent peak valuation of high-20s next twelve months (NTM) EV/EBITDA, while management's traditionally cautious stance limits the likelihood of guidance exceeding consensus estimates. Still, Evercore maintained its Outperform rating on the stock, describing the TAP call as tactical rather than a change in its longer-term view. 'We still believe AFRM has the best risk platform in the space and will benefit over the longer-term from penetration in new verticals and geographies as well as product expansion,' the analysts led by Adam Frisch wrote. Investors are awaiting Affirm's fiscal fourth-quarter earnings on Aug. 28, when management will outline fiscal 2026 guidance. Evercore expects guidance to be broadly in line with consensus, with gross merchandise volume (GMV) seen growing 27% ex-Walmart and revenue less transaction costs (RLTC) margin at 3.9%. The firm noted risks tied to potential GMV declines at Walmart (NYSE:WMT), which accounts for about 5% of Affirm's volume, after competitor Klarna expanded its OnePay offering. Analysts also pointed to a margin dynamic. Notably, lower Walmart volumes could prove accretive given the partnership's lower economics, though this might be offset by the continued growth in 0% annual percentage rate (APR) loans. Over the past four quarters, Affirm has averaged a Revenue Less Transaction (JO:NTUJ) Costs (RLTC) margin of 4.1%, above management's 3-4% target. 'We expect a 3.9% RLTC margin for FY26 (down 14bps YoY and in line with consensus) but note that could prove a little conservative with continued execution,' analysts said. Related articles Evercore adds Affirm to its Tactical Underperform list After soaring 149%, this stock is back in our AI's favor - & already +25% in July 7 Undervalued Stocks on the Rise With 50%+ Upside Potential Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
11 minutes ago
- Yahoo
What Makes Mama's Creations (MAMA) a Compelling Investment?
Immersion Investment Partners, an investment management company, released its second-quarter 2025 investor letter. A copy of the same can be downloaded here. The fund gained 28.13% in the second quarter, compared to an 8.50% increase for the Russell 2000 Index and a 15.51% increase for the Russell Microcap Index. The firm focuses on the company fundamentals, not on quarterly stock price performance. The firm invested over 80% of net asset value in the top five names. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second-quarter 2025 investor letter, Immersion Investment Partners highlighted stocks such as Mama's Creations, Inc. (NASDAQ:MAMA). Mama's Creations, Inc. (NASDAQ:MAMA) manufactures and markets fresh deli-prepared foods. The one-month return of Mama's Creations, Inc. (NASDAQ:MAMA) was -11.30%, and its shares lost 0.97% of their value over the last 52 weeks. On August 18, 2025, Mama's Creations, Inc. (NASDAQ:MAMA) stock closed at $8.16 per share, with a market capitalization of $306.903 million. Immersion Investment Partners stated the following regarding Mama's Creations, Inc. (NASDAQ:MAMA) in its second quarter 2025 investor letter: "Mama's Creations, Inc. (NASDAQ:MAMA): Occasionally you run across an executive who is so outlandishly passionate about their job and the brand they represent, you can't help but take notice. We first met Adam Michaels (CEO of MAMA) more than a year ago at an investor conference. Clad in mulberry shoes and sport coat, the exact brand colors of MAMA, he told us how he would take what was historically a subscale meatball manufacturer in suburban New Jersey and make it into one of the largest prepared foods and deli brands in the world. Frankly, we thought he had too many screws loose. Nonetheless, we were intrigued by the business and the category. Fresh and prepared foods in grocery stores has been a growing category, catalyzed by consumer demand for healthier, fast, and affordable food options. Grocery stores have been increasingly dedicating more food space to the category. Today, it is one of only a couple of categories that are seeing volume growth. Mama's Creations, Inc. (NASDAQ:MAMA) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 7 hedge fund portfolios held Mama's Creations, Inc. (NASDAQ:MAMA) at the end of the first quarter, which was 8 in the previous quarter. Mama's Creations, Inc.'s (NASDAQ:MAMA) fiscal Q1 2026 revenue grew approximately 18% year over year, to a record $35.3 million. While we acknowledge the potential of Mama's Creations, Inc. (NASDAQ:MAMA) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
11 minutes ago
- Yahoo
Does LifeCore (LFCR) Have a High Expected Value?
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here. In the second quarter, the fund returned approximately +14% net of fees and expenses, bringing the YTD returns to under +1%. YTD, the Russell 2000 has returned -1.8%. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second-quarter 2025 investor letter, Greenhaven Road Capital highlighted stocks such as Lifecore Biomedical, Inc. (NASDAQ:LFCR). Lifecore Biomedical, Inc. (NASDAQ:LFCR) is an integrated contract development and manufacturing organization. The one-month return of Lifecore Biomedical, Inc. (NASDAQ:LFCR) was -0.54%, and its shares gained 30.05% of their value over the last 52 weeks. On August 18, 2025, Lifecore Biomedical, Inc. (NASDAQ:LFCR) stock closed at $7.40 per share, with a market capitalization of $276.818 million. Greenhaven Road Capital stated the following regarding Lifecore Biomedical, Inc. (NASDAQ:LFCR) in its second quarter 2025 investor letter: "Another holding that I believe has a high expected value is Lifecore Biomedical, Inc. (NASDAQ:LFCR), which I have written about extensively. Here is a link to a recent presentation (link) I did for the investing platform SumZero. Kyle and I visited the manufacturing facility in Minnesota during the quarter and spent time with management and the business development team. As a reminder, LifeCore is a contract drug manufacturer which has recently added significant manufacturing capacity. They are operating at approximately 20% of their capacity with 15% EBITDA margins. A village pharmacist fulfilling a patient's medication prescription in a rural area. Lifecore Biomedical, Inc. (NASDAQ:LFCR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 12 hedge fund portfolios held Lifecore Biomedical, Inc. (NASDAQ:LFCR) at the end of the first quarter compared to 10 in the previous quarter. While we acknowledge the potential of Lifecore Biomedical, Inc. (NASDAQ:LFCR) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Lifecore Biomedical, Inc. (NASDAQ:LFCR) and shared Laughing Water Capital's views on the company. Greenhaven Road Capital increased its stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR) in the previous quarter to nearly 10%. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
